Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-07-30

Clinical Trial Update: An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update evaluating topical cromolyn sodium for rosacea-associated erythema in phase 1 and phase 2, with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • cromolyn sodium (topical) (cromolyn sodium)

Snippet

Sponsor: University of California, San Diego | Conditions: Papulopustular Rosacea | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-07-30